These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5531365)

  • 1. On the mechanism of action of galactosamine: different response to D-galactosamine of rat liver during development.
    Reutter W; Bauer C; Lesch R
    Naturwissenschaften; 1970 Dec; 57(12):674-5. PubMed ID: 5531365
    [No Abstract]   [Full Text] [Related]  

  • 2. Orotate prevents galactosamine hepatitis.
    Keppler D; Rudigier J; Reutter W; Lesch R; Decker K
    Hoppe Seylers Z Physiol Chem; 1970 Jan; 351(1):102-4. PubMed ID: 5411959
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective role of prednisolone upon galactosamine-induced hepatitis in rats.
    Grases PJ; Reutter W; Lesch R
    G E N; 1972; 27(2):197-204. PubMed ID: 4201408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Galactosamine-hepatitis].
    Reutter W; Lesch R; Keppler D; Decker K
    Naturwissenschaften; 1968 Oct; 55(10):497. PubMed ID: 5701857
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver injury induced by 2-deoxy-D-galactose.
    Keppler DO; Hübner G
    Exp Mol Pathol; 1973 Dec; 19(3):365-77. PubMed ID: 4763635
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigations on d-galactosamine hepatitis after pretreatment with alpha-hexachlorocyclohexane.
    Schuchhardt C; Reutter W; Lesch R
    Beitr Pathol; 1976 Feb; 157(1):45-55. PubMed ID: 57771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of severity of toxic hepatitis in acute poisoning with chlorinated hydrocarbons after changes of the activity of aminotransferases and sorbitol dehydrogenase].
    Natsiuk MV; Lipkan GN; Chernukha FS
    Gig Tr Prof Zabol; 1974 Jun; 18(6):53. PubMed ID: 4845523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 9. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of the hepatotoxic effects of D-galactosamine by D-galactose.
    Mészáros K; Antoni F; Hrabák A; Szikla C; Garzó T; Tompa A; Lapis K
    FEBS Lett; 1973 Sep; 35(1):1-3. PubMed ID: 4751995
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice.
    Wendel A; Tiegs G
    Biochem Pharmacol; 1986 Jul; 35(13):2115-8. PubMed ID: 3729968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive effect of modified arabinoxylan from rice bran (MGN-3) on D-galactosamine-induced IL-18 expression and hepatitis in rats.
    Zheng S; Sanada H; Dohi H; Hirai S; Egashira Y
    Biosci Biotechnol Biochem; 2012; 76(5):942-6. PubMed ID: 22738964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK 506 modulates D-galactosamine-induced hepatitis in rats.
    Farghali H; Gasbarrini A; Borle AB; Nalesnik MA; Francavilla A; Fagiuoli S; Starzl TE; Van Thiel DH
    Transplant Proc; 1991 Dec; 23(6):2809-11. PubMed ID: 1721285
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlations of enzyme activities in serum after experimental liver damage in rats].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1971 Aug; 21(8):1201-5. PubMed ID: 5110019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental animal studies on giant cell hepatitis in baby rats after galactosamine administration to pregnant rats].
    Leinweber B; Platt D
    Klin Wochenschr; 1970 Sep; 48(17):1072-3. PubMed ID: 5535581
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine.
    Perings E; Brunner G; Vido I; Söling HD; Creutzfeldt W
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):130-4. PubMed ID: 4148023
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
    Pickering RW; Lynn James GW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.